BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malfertheiner P, Nocon M, Vieth M, Stolte M, Jaspersen D, Koelz HR, Labenz J, Leodolter A, Lind T, Richter K. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care-the ProGERD study. Aliment Pharmacol Ther. 2012;35:154-164. [PMID: 22070159 DOI: 10.1111/j.1365-2036.2011.04901.x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 62] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Shaheen NJ, Falk GW, Iyer PG, Souza RF, Yadlapati RH, Sauer BG, Wani S. Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. Am J Gastroenterol 2022;117:559-87. [PMID: 35354777 DOI: 10.14309/ajg.0000000000001680] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
2 Gkolfakis P, Lorenzo D, Blero D, Louis H, Lemmers A, Arvanitakis M, Eisendrath P, Devière J. Pneumatic dilation for the treatment of persistent post-laparoscopic fundoplication dysphagia: long-term efficacy and safety. Expert Rev Gastroenterol Hepatol 2022;16:289-96. [PMID: 35235494 DOI: 10.1080/17474124.2022.2049241] [Reference Citation Analysis]
3 Shah A, Shibli F, Kitayama Y, Fass R. The Natural Course of Gastroesophageal Reflux Disease: A Critical Appraisal of the Literature. J Clin Gastroenterol 2021;55:12-20. [PMID: 32909972 DOI: 10.1097/MCG.0000000000001419] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Graham DY, Tan MC. No Barrett's-No Cancer: A Proposed New Paradigm for Prevention of Esophageal Adenocarcinoma. J Clin Gastroenterol 2020;54:136-43. [PMID: 31851107 DOI: 10.1097/MCG.0000000000001298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Fuchs KH, DeMeester TR, Otte F, Broderick RC, Breithaupt W, Varga G, Musial F. Severity of GERD and disease progression. Dis Esophagus 2021:doab006. [PMID: 33575739 DOI: 10.1093/dote/doab006] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Leeds SG, Ward MA. Magnetic Sphincter Augmentation: Poor Consensus Among Experts Regarding Key Technical Aspects of Implantation. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2021;31:36-9. [DOI: 10.1097/sle.0000000000000847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Huynh P, Konda V, Sanguansataya S, Ward MA, Leeds SG. Mind the Gap: Current Treatment Alternatives for GERD Patients Failing Medical Treatment and Not Ready for a Fundoplication. Surg Laparosc Endosc Percutan Tech 2020;31:264-76. [PMID: 33347088 DOI: 10.1097/SLE.0000000000000888] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Wiens E, Kovaltchouk U, Koomson A, Targownik LE. The Clinician's Guide to Proton-Pump Inhibitor Discontinuation. J Clin Gastroenterol 2019;53:553-9. [PMID: 31356559 DOI: 10.1097/MCG.0000000000001243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ferraz ÁAB, da Silva JD, Santa-cruz F, Aquino MR, Siqueira LT, Kreimer F. The Impact of the Gastric Twist on Esophagitis Progression After Sleeve Gastrectomy: Mid-Term Endoscopic Findings. OBES SURG 2020;30:4452-8. [DOI: 10.1007/s11695-020-04838-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ogle S, Derderian SC, Kramer R, Anthony R, Inge T. The role of preoperative upper endoscopy in adolescents undergoing laparoscopic vertical sleeve gastrectomy. Surg Obes Relat Dis 2020;16:1212-7. [PMID: 32576512 DOI: 10.1016/j.soard.2020.04.051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bonavina L, Fisichella PM, Gavini S, Lee YY, Tatum RP. Clinical course of gastroesophageal reflux disease and impact of treatment in symptomatic young patients. Ann N Y Acad Sci 2020;1481:117-26. [PMID: 32266986 DOI: 10.1111/nyas.14350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 DeMeester SR. Laparoscopic Hernia Repair and Fundoplication for Gastroesophageal Reflux Disease. Gastrointest Endosc Clin N Am 2020;30:309-24. [PMID: 32146948 DOI: 10.1016/j.giec.2019.12.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Bi D, Katzka DA, Lavey CJ, Geno DM, Ravi K. Erosive Esophagitis Portends a Benign Clinical Course in the Majority of Patients. Dig Dis Sci 2020;65:3244-52. [PMID: 31907769 DOI: 10.1007/s10620-019-06027-1] [Reference Citation Analysis]
14 Wang K, Zhang L, He ZH, Liu ZJ, Zhang L, Hu N, Jin Z, Ke Y, Duan LP. A population-based survey of gastroesophageal reflux disease in a region with high prevalence of esophageal cancer in China. Chin Med J (Engl) 2019;132:1516-23. [PMID: 31045906 DOI: 10.1097/CM9.0000000000000275] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
15 Chandrasoma P. New evidence defining the pathology and pathogenesis of lower esophageal sphincter damage. Eur Surg 2019;51:282-90. [DOI: 10.1007/s10353-019-00616-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
16 Chandrasoma P. How the pathologist can aid in the assessment of gastroesophageal reflux disease. Curr Opin Gastroenterol 2018;34:233-42. [PMID: 29708896 DOI: 10.1097/MOG.0000000000000446] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
17 Hunt R, Armstrong D, Katelaris P, Afihene M, Bane A, Bhatia S, Chen MH, Choi MG, Melo AC, Fock KM, Ford A, Hongo M, Khan A, Lazebnik L, Lindberg G, Lizarzabal M, Myint T, Moraes-Filho JP, Salis G, Lin JT, Vaidya R, Abdo A, LeMair A; Review Team:. World Gastroenterology Organisation Global Guidelines: GERD Global Perspective on Gastroesophageal Reflux Disease. J Clin Gastroenterol. 2017;51:467-478. [PMID: 28591069 DOI: 10.1097/mcg.0000000000000854] [Cited by in Crossref: 56] [Cited by in F6Publishing: 71] [Article Influence: 18.7] [Reference Citation Analysis]
18 Chwiesko A, Kowal-Bielecka O, Sierakowski S. Perspectives on the interlinked nature of systemic sclerosis and reflux disease. Expert Rev Gastroenterol Hepatol. 2019;13:213-227. [PMID: 30791766 DOI: 10.1080/17474124.2019.1561274] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
19 de Bortoli N, Tolone S, Frazzoni M, Martinucci I, Sgherri G, Albano E, Ceccarelli L, Stasi C, Bellini M, Savarino V, Savarino EV, Marchi S. Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders. Ann Gastroenterol 2018;31:639-48. [PMID: 30386113 DOI: 10.20524/aog.2018.0314] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
20 Labenz J, Chandrasoma PT, Knapp LJ, DeMeester TR. Proposed approach to the challenging management of progressive gastroesophageal reflux disease. World J Gastrointest Endosc 2018; 10(9): 175-183 [PMID: 30283600 DOI: 10.4253/wjge.v10.i9.175] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
21 Fuchs KH, Musial F, Ulbricht F, Breithaupt W, Reinisch A, Babic B, Fuchs H, Varga G. Foregut symptoms, somatoform tendencies, and the selection of patients for antireflux surgery. Dis Esophagus. 2017;30:1-10. [PMID: 28475727 DOI: 10.1093/dote/dox022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
22 Asti E, Aiolfi A, Lazzari V, Sironi A, Porta M, Bonavina L. Magnetic sphincter augmentation for gastroesophageal reflux disease: review of clinical studies. Updates Surg 2018;70:323-30. [DOI: 10.1007/s13304-018-0569-6] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
23 Wilder-Smith CH, Materna A, Martig L, Lussi A. Longitudinal study of gastroesophageal reflux and erosive tooth wear. BMC Gastroenterol 2017;17:113. [PMID: 29070010 DOI: 10.1186/s12876-017-0670-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
24 Savarino E, de Bortoli N, De Cassan C, Della Coletta M, Bartolo O, Furnari M, Ottonello A, Marabotto E, Bodini G, Savarino V. The natural history of gastro-esophageal reflux disease: a comprehensive review. Dis Esophagus. 2017;30:1-9. [PMID: 27862680 DOI: 10.1111/dote.12511] [Cited by in Crossref: 16] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
25 Johnson DA, Katz PO, Armstrong D, Cohen H, Delaney BC, Howden CW, Katelaris P, Tutuian RI, Castell DO. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus. Drugs 2017;77:547-61. [PMID: 28233274 DOI: 10.1007/s40265-017-0712-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
26 Mastracci L, Fiocca R, Engström C, Attwood S, Ell C, Galmiche JP, Hatlebakk JG, Långström G, Eklund S, Lind T, Lundell L. The dynamics of the oesophageal squamous epithelium ‘normalisation’ process in patients with gastro-oesophageal reflux disease treated with long-term acid suppression or anti-reflux surgery. Aliment Pharmacol Ther 2017;45:1339-49. [DOI: 10.1111/apt.14038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
27 Fukuda N, Ishimura N, Okada M, Izumi D, Mikami H, Okimoto E, Aimi M, Mishiro T, Oshima N, Ishihara S, Kinoshita Y. Mucosal breaks show same circumferential distribution in majority of patients with recurrent reflux esophagitis. Endosc Int Open 2017;5:E214-21. [PMID: 28317018 DOI: 10.1055/s-0043-102401] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
28 Labenz J. [Barrett's esophagus]. Internist (Berl) 2016;57:1079-92. [PMID: 27757487 DOI: 10.1007/s00108-016-0152-5] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
29 Manabe N, Haruma K. Optimal acid suppressive treatment for adequate symptom relief and prevention of the complications of gastroesophageal reflux disease: differences in long-term clinical course and pathophysiology among disease subtypes. Esophagus 2017;14:113-21. [DOI: 10.1007/s10388-016-0558-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Sriratanaviriyakul N, Kivler C, Vidovszky TJ, Yoneda KY, Kenyon NJ, Murin S, Louie S. LINX®, a novel treatment for patients with refractory asthma complicated by gastroesophageal reflux disease: a case report. J Med Case Rep 2016;10:124. [PMID: 27220906 DOI: 10.1186/s13256-016-0887-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
31 Dunbar KB, Agoston AT, Odze RD, Huo X, Pham TH, Cipher DJ, Castell DO, Genta RM, Souza RF, Spechler SJ. Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes. JAMA 2016;315:2104-12. [PMID: 27187303 DOI: 10.1001/jama.2016.5657] [Cited by in Crossref: 127] [Cited by in F6Publishing: 101] [Article Influence: 21.2] [Reference Citation Analysis]
32 Martinucci I, de Bortoli N, Russo S, Bertani L, Furnari M, Mokrowiecka A, Malecka-Panas E, Savarino V, Savarino E, Marchi S. Barrett’s esophagus in 2016: From pathophysiology to treatment. World J Gastrointest Pharmacol Ther 2016; 7(2): 190-206 [PMID: 27158534 DOI: 10.4292/wjgpt.v7.i2.190] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
33 Nathanson BH, Navab F. An Analysis of Weight Gains and Body Mass Index in Patients with Barrett's Esophagus. J Acad Nutr Diet 2016;116:1156-62. [PMID: 27102137 DOI: 10.1016/j.jand.2016.03.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Tatarian T, Pucci MJ, Palazzo F. A Modern Approach to the Surgical Treatment of Gastroesophageal Reflux Disease. Journal of Laparoendoscopic & Advanced Surgical Techniques 2016;26:174-9. [DOI: 10.1089/lap.2015.0530] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
35 Labenz J, Labenz C. Prävalenz und natürlicher Verlauf der gastroösophagealen Refluxkrankheit. Gastroenterologe 2016;11:102-9. [DOI: 10.1007/s11377-016-0045-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
36 Navab F, Nathanson BH, Desilets DJ. The impact of lifestyle on Barrett's Esophagus: A precursor to esophageal adenocarcinoma. Cancer Epidemiol 2015;39:885-91. [PMID: 26519660 DOI: 10.1016/j.canep.2015.10.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
37 Ganz RA, Edmundowicz SA, Taiganides PA, Lipham JC, Smith CD, DeVault KR, Horgan S, Jacobsen G, Luketich JD, Smith CC, Schlack-Haerer SC, Kothari SN, Dunst CM, Watson TJ, Peters J, Oelschlager BK, Perry KA, Melvin S, Bemelman WA, Smout AJ, Dunn D. Long-term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal Reflux. Clin Gastroenterol Hepatol. 2016;14:671-677. [PMID: 26044316 DOI: 10.1016/j.cgh.2015.05.028] [Cited by in Crossref: 121] [Cited by in F6Publishing: 90] [Article Influence: 17.3] [Reference Citation Analysis]
38 Bennett C, Moayyedi P, Corley DA, DeCaestecker J, Falck-Ytter Y, Falk G, Vakil N, Sanders S, Vieth M, Inadomi J. BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol. 2015;110:662-682; quiz 683. [PMID: 25869390 DOI: 10.1038/ajg.2015.55] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 11.4] [Reference Citation Analysis]
39 DeMeester SR. Barrett's oesophagus: treatment with surgery. Best Pract Res Clin Gastroenterol 2015;29:211-7. [PMID: 25743467 DOI: 10.1016/j.bpg.2014.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
40 Reynolds JL, Zehetner J, Wu P, Shah S, Bildzukewicz N, Lipham JC. Laparoscopic Magnetic Sphincter Augmentation vs Laparoscopic Nissen Fundoplication: A Matched-Pair Analysis of 100 Patients. J Am Coll Surg. 2015;221:123-128. [PMID: 26095560 DOI: 10.1016/j.jamcollsurg.2015.02.025] [Cited by in Crossref: 76] [Cited by in F6Publishing: 61] [Article Influence: 10.9] [Reference Citation Analysis]
41 DeMeester SR. Optimizing Patient Selection and Outcomes for Surgical Treatment of GERD and Achalasia. Curr Treat Options Gastroenterol 2015;13:1-15. [PMID: 25595928 DOI: 10.1007/s11938-014-0035-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
42 Zerbib F. The prevalence of oesophagitis in “silent” gastro-oesophageal reflux disease: Higher than expected? Digestive and Liver Disease 2015;47:12-3. [DOI: 10.1016/j.dld.2014.10.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
43 Worrell SG, Greene CL, DeMeester TR. The state of surgical treatment of gastroesophageal reflux disease after five decades. J Am Coll Surg. 2014;219:819-830. [PMID: 25241236 DOI: 10.1016/j.jamcollsurg.2014.05.018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
44 Braxton DR, Nickleach DC, Liu Y, Farris AB 3rd. Necrotizing sialometaplasia-like change of the esophageal submucosal glands is associated with Barrett's esophagus. Virchows Arch 2014;465:135-43. [PMID: 24863247 DOI: 10.1007/s00428-014-1590-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
45 Fuchs KH, Babic B, Breithaupt W, Dallemagne B, Fingerhut A, Furnee E, Granderath F, Horvath P, Kardos P, Pointner R, Savarino E, Van Herwaarden-Lindeboom M, Zaninotto G;  European Association of Endoscopic Surgery (EAES). EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc. 2014;28:1753-1773. [PMID: 24789125 DOI: 10.1007/s00464-014-3431-z] [Cited by in Crossref: 108] [Cited by in F6Publishing: 88] [Article Influence: 13.5] [Reference Citation Analysis]
46 Ronkainen J, Agréus L. Epidemiology of reflux symptoms and GORD. Best Pract Res Clin Gastroenterol 2013;27:325-37. [PMID: 23998972 DOI: 10.1016/j.bpg.2013.06.008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
47 Tielemans MM, van Oijen MG. Online follow-up of individuals with gastroesophageal reflux disease using a patient-reported outcomes instrument: results of an observational study. BMC Gastroenterol 2013;13:144. [PMID: 24083342 DOI: 10.1186/1471-230X-13-144] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
48 Quante M, Abrams JA, Wang TC. The rapid rise in gastroesophageal junction tumors: is inflammation of the gastric cardia the underwater iceberg? Gastroenterology. 2013;145:708-711. [PMID: 23978439 DOI: 10.1053/j.gastro.2013.08.023] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
49 Ren D, Zheng G, Bream S, Tevebaugh W, Shaheen NJ, Chen X. Single nucleotide polymorphisms of caudal type homeobox 1 and 2 are associated with Barrett's esophagus. Dig Dis Sci 2014;59:57-63. [PMID: 23918153 DOI: 10.1007/s10620-013-2804-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
50 Bonavina L, Saino G, Lipham JC, Demeester TR. LINX(®) Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux. Therap Adv Gastroenterol 2013;6:261-8. [PMID: 23814607 DOI: 10.1177/1756283X13486311] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
51 Estores D, Velanovich V. Barrett esophagus: epidemiology, pathogenesis, diagnosis, and management. Curr Probl Surg. 2013;50:192-226. [PMID: 23601575 DOI: 10.1067/j.cpsurg.2013.01.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
52 Bruley des Varannes S, Löfman HG, Karlsson M, Wahlqvist P, Ruth M, Furstnau ML, Despiégel N, Stålhammar NO. Cost and burden of gastroesophageal reflux disease among patients with persistent symptoms despite proton pump inhibitor therapy: an observational study in France. BMC Gastroenterol. 2013;13:39. [PMID: 23448382 DOI: 10.1186/1471-230X-13-39] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
53 Shaheen NJ, Denison H, Björck K, Silberg DG. Esophageal mucosal breaks in gastroesophageal reflux disease partially responsive to proton pump inhibitor therapy. Am J Gastroenterol 2013;108:529-34. [PMID: 23318482 DOI: 10.1038/ajg.2012.447] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
54 Stålhammar NO, Spiegel BM, Granstedt Löfman H, Karlsson M, Wahlqvist P, Næsdal J, Nelson MT, Despiégel N. Partial response to proton pump inhibitor therapy for GERD: observational study of patient characteristics, burden of disease, and costs in the USA. Pragmat Obs Res 2012;3:57-67. [PMID: 27774018 DOI: 10.2147/POR.S36704] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
55 Mesteri I, Beller L, Fischer-see S, Schoppmann S, Lenglinger J, Wrba F, Riegler M, Zacherl J. Radiofrequency ablation of Barrett’s esophagus and early cancer within the background of the pathophysiology of the disease. Eur Surg 2012;44:366-82. [DOI: 10.1007/s10353-012-0183-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
56 Jansson C, Wiberg M, Alexanderson K. Sickness absence due to gastroesophageal reflux diagnoses: a nationwide Swedish population-based study. Scand J Gastroenterol 2013;48:17-26. [PMID: 23181538 DOI: 10.3109/00365521.2012.737359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
57 Huerta-Iga FM, Tamayo-de la Cuesta JL, Noble-Lugo A, Remes-Troche JM, Valdovinos-Díaz MA, Carmona-Sánchez RI; el Grupo Mexicano para el Estudio de la Enfermedad por Reflujo Gastroesofágico 2011. [The Mexican consensus on gastroesophageal reflux disease. Part I]. Rev Gastroenterol Mex 2012;77:193-213. [PMID: 23153413 DOI: 10.1016/j.rgmx.2012.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
58 Mesteri I, Lenglinger J, Beller L, Fischer-see S, Schoppmann SF, Wrba F, Riegler FM, Zacherl J. Assessment of columnar-lined esophagus in controls and patients with gastroesophageal reflux disease with and without proton-pump inhibitor therapy. Eur Surg 2012;44:304-13. [DOI: 10.1007/s10353-012-0159-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
59 Jonasson C, Moum B, Bang C, Andersen KR, Hatlebakk JG. Randomised clinical trial: a comparison between a GerdQ-based algorithm and an endoscopy-based approach for the diagnosis and initial treatment of GERD. Aliment Pharmacol Ther. 2012;35:1290-1300. [PMID: 22510027 DOI: 10.1111/j.1365-2036.2012.05092.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
60 Aro P, Ronkainen J. Evolution of GERD over 5 years. Aliment Pharmacol Ther 2012;35:393-4; discussion 395-6. [PMID: 22221083 DOI: 10.1111/j.1365-2036.2011.04943.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
61 Malfertheiner P. Evolution of GERD over 5 years: author’s reply: Invited Commentaries. Alimentary Pharmacology & Therapeutics 2012;35:395-6. [DOI: 10.1111/j.1365-2036.2011.04961.x] [Reference Citation Analysis]
62 Kandulski A, Malfertheiner P. Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation. Nat Rev Gastroenterol Hepatol. 2012;9:15-22. [PMID: 22105108 DOI: 10.1038/nrgastro.2011.210] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]